Arovella Therapeutics Ltd
ASX:ALA

Watchlist Manager
Arovella Therapeutics Ltd Logo
Arovella Therapeutics Ltd
ASX:ALA
Watchlist
Price: 0.18 AUD -5.26% Market Closed
Market Cap: 189.3m AUD
Have any thoughts about
Arovella Therapeutics Ltd?
Write Note

Arovella Therapeutics Ltd
Current Portion of Long-Term Debt

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Arovella Therapeutics Ltd
Current Portion of Long-Term Debt Peer Comparison

Comparables:
MYX
NEU
BOT
PBP
VLS

Competitive Current Portion of Long-Term Debt Analysis
Latest Figures & CAGR of Competitors

Company Current Portion of Long-Term Debt CAGR 3Y CAGR 5Y CAGR 10Y
Arovella Therapeutics Ltd
ASX:ALA
Current Portion of Long-Term Debt
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Mayne Pharma Group Ltd
ASX:MYX
Current Portion of Long-Term Debt
AU$3.8m
CAGR 3-Years
-32%
CAGR 5-Years
-23%
CAGR 10-Years
N/A
Neuren Pharmaceuticals Ltd
ASX:NEU
Current Portion of Long-Term Debt
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Botanix Pharmaceuticals Ltd
ASX:BOT
Current Portion of Long-Term Debt
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Probiotec Ltd
ASX:PBP
Current Portion of Long-Term Debt
AU$7m
CAGR 3-Years
35%
CAGR 5-Years
2%
CAGR 10-Years
-7%
Vita Life Sciences Ltd
ASX:VLS
Current Portion of Long-Term Debt
AU$302k
CAGR 3-Years
11%
CAGR 5-Years
-14%
CAGR 10-Years
N/A

See Also

Back to Top